Clinical Trial Update: Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial enrolling by invitation to evaluate haploidentical HSCT combined with hypoxic 3D-cultured umbilical cord MSCs for the treatment of seve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Haploidentical hematopoietic stem cell transplantation (Haplo-HSCT)
• Hypoxic 3D-cultured umbilical cord mesenchymal stem cells

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION